are now planned to extend to 16 days with NASA's space shuttle orbiter (Shuttle), to 90 days with Space Station Freedom (5SF), and possibly to 1000 days for exploration missions of the moon and Mars.7 The Russian Space Station Mir has provided long-duration missions of 6 months to 1 year for one to three crew members.
Physiological adaptations
to space are studied because of concern for the health of astronauts and to determine the need for and effectiveness of appropriate countermeasures. and would remain docked at the station throughout the mission. Missions as long as 90 These additions would permit resuscitation, stabilization, and intensive care of a seriously ill or injured crew member at SSF for as long as 3 days. Hyperbaric treatment capability is planned as part of extravehicular activity airlock systems. Medical transport capability from SSF to a definitive medical care facility on Earth within 24 h of a decision to transport is planned via an Assured Crew Return Vehicle (9) .
Human exploration of the moon and Mars is in early planning (10, 
11). The current focus is a First Lunar
Outpost mission of 45 days. Planned lunar missions of 14 days to 2 years and Mars missions of 500-1000 days have been described. The primary activity of explorers would be "fieldwork" to chart and examine the planet's surface, obtain mineralogical and water samples, and set up and maintain astronomy equipment and additional outpost facilities. The work would involve extensive use of protective pressurized suits and portable life-support systems. The health and performance of each exploration crew member are basic to its planning and will be essential for mission success.
Return
to Earth would require several days from a lunar outpost and several weeks to months from a Mars mission. The delivery of medical care on site would therefore be a very important operational capability for exploration missions, because the need to return an individual to Earth for medical care would require that the entire crew return, the mission be aborted, and the outpost be (temporarily) abandoned. Also, a prognostic capability that at present does not exist would be needed to plan a successful long-term transport.
To plan a survivable medical transport of a crew member from a lunar outpost, we must be able to project over several days the clinical course and condition of a crew member.
Physiological adaptation to self-contained, micro-and partial-gravity environments, as well as radiation hazards of exploration missions, could introduce health and potential medical care concerns that would require periodic or continuous monitoring. Illness or injury, possibly complicated by adaptation stresses, would therefore require prepared, informed response. Concepts of health and medical-care systems for space exploration have been described, based primarily on the technical evolution of current concepts (12) .
Laboratory DIagnostic RequIrements for MedIcal Care In Space
Clinical medical care during long-duration spacemissions is emerging as an important part of program planning (13) (14) (15) (16) respiratory therapy, physical therapy, and other services. In contrast with current Earth-based critical care, extreme limitations of volume and weight of equipment and supplies and of the number of personnel available to deliver care are likely. Patient capacity of a medical-care system in space is an important design factor, particularly when the volume and mass of equipment and supplies are severely restricted. One patient bed unit is planned for a crew of four to eight at a planet surface outpost, with duplication if necessary (12) . Efficiency of the caregiver(s), including ready access to equipment and supplies, will 
A.
microscopy and automated culture analysis (AutoMicrobic System; Vitek Systems Inc., St. Louis, MO). This subsystem might not be located near the HMF, so that sample transport from a patient to this facility would be necessary.
Physiological Adaptations to Space and Effects on ClInIcal ChemIcal Variables
Many physiological changes occur before, during, and after humans are exposed to space (see Figure 1) . These changes are initiated by the fluid shifts that occur because of the absence of Earth-normal gravity and the stress associated with space flight (27) 
ElectrolyteTestingin Relation to Fluid Shifts
The redistribution of fluids as a result of weightlessness has significant effects on water and electrolyte balance (29). An estimated 0.5-3 L of blood is rapidly redistributed between the lower extremities and the central blood volume. Preliminary results of the recent Spacelab Life Sciences 1 mission indicate that fluid shifting occurs before and soon after launch (30). Central osmo-and neuroreceptors perceive this shift as an increase in the total blood volume. Under Earth-normal gravity conditions, volume expansion leads to diuresis, a decrease in the thirst sensation, and an increase in the glomerular filtration rate (GFR). During Skylab, GFR estimated by creatinine clearance was shown to be increased during space ifight (31). However, because serum creatiine concentration was also increased (32) , possibly as the result of skeletal muscle turnover, the indication of increased GFR may have been inaccurate. Nevertheless, inulin studies during Spacelab Life Sciences 1 also showed that GFR increased under Earthnormal gravity conditions (28) . In contrast, renal plasma flow, as measured by plasma p-aminohippurate (33), decreased (30), which may increase the risk for nephrolithiasis (see below). The shift of blood volume from the extremities, especially the legs, is apparently sensed as an increase in blood volume. Adjustment of blood volume results in diuresis and depletion of electrolytes and total body water. Results from Skylab showed serum sodium activity inf light to be less than that during preffight, whereas potassium activity was slightly increased (Figure 2 ). These adaptations are consistent with the observed decrease in the release of antidiuretic hormone ( Figure  2) , renin, and aldosterone, and an increase in atrial natriuretic factor. However, during Spacelab Life Sciences 1, atrial natriuretic factor decreased by 20% during the first 6-8 h in orbit, indicating that this factor is probably not involved with the early diuresis observed (28).
C.

ENDOCIINE RESPONSE HORMONAL
TO MISSIONSTRESS DERANGEMENTS IWvIUNE
Because vascular volume redistribution is due to a
shift of fluid toward the head and not to an actual increase in blood volume, astronauts are usually dehydrated during the first few days of a mission, and a conscious effort is made to maintain adequate water intake. Indeed, most Skylab astronauts lost weight, mostly attributable to a negative water balance, as determined by intake and excretion measurements (32) . The cardiovascular adaptation of fluid shifts in microgravity includes a decrease in heart size, stroke volume, and left ventricular end-diastolic volume. The resetting of these sympathetic regulatory mechanisms produces an orthostatic intolerance upon return to Earth, including tachycardia and a syncopal decrease of blood pressure. These effects can last for 2-3 days after returning to Earth. An effective countermeasure to this intolerance is fluid loading with saline just before re-exposure to gravity. However, excessive fluid replacement and loading early in a long-duration mission may retard normal cardiovascular adaptation and may be counterproductive (29) .
For long-duration space missions, analysis of serum and urine for electrolytes should be a vital part of routine health monitoring, in addition to monitoring the status of these analytes during acute injury or illness. The capability for measurement of serum sodium, potassium, and chloride activities-as components of osmotic fluid balance-could be particularly important. The capability for measurement of magnesium concentration could provide important information about nutritional status.
Total CO2 measurements would also be a reliable indicator of buffering capacity and ventilatory status. In combination with arterial and venous whole-blood pH analysis, measurements of airway end-tidal CO2 gas concentration measurement and lung mechanical function would provide an accurate assessment of ventilation. The capability for complete blood gas analysis, to include P02, Pco2, pH, and hemoglobin, in combination with inspired and expired gas analysis and lung mechanical functions, would permit assessment of oxygenation, ventilation, and work capacity.
Osmotic Measurements for Health Monitoring
Serum osmolality has important applications in monitoring treatment of cerebral edema and chemical intoxication. Confirming (41, 44, 45 (40) (41) (42) . Urinary hydroxyproline measurements may also be useful in monitoring increased bone turnover (40) . Most of the urine excretions have been measured in 24-h samples. However, calculating the calcium/creatinine and hydroxyproline/ creatinine ratios from a 2-h urine collection may provide a useful and more practical means of monitoring bone loss (47) . Inflight total serum calcium concentrations are higher than preffight values but are still within the normal range (40) (41) (42) . Better sensitivity to these minor metabolic disturbances might be observed with measurements of serum ionized calcium.
ElectrolyteTestingin Relationto Renal Stone Formation
Because of an increased knowledge of its pathophysiological mechanisms and the development of new surgical therapies for it, nephrolithiasis is a disorder that is fairly well managed on Earth today (48 
Endocrine Testing in Relation to Stress
The launch and the first few days of space travel are Recent animal and human studies show that cortisol secretion is more linked with light and darkness cycles than with sleepwake cycles (60) (61) (62) (26) . These analyses would be used to diagnose toxic, infectious, and traumatic liver injury.
Pharmacokinetics and Therapeutic Drug Monitonng
Therapeutic drugs are used during Shuttle missions for treating space motion sickness (64) . Unfortunately, (27) .
The rate of absorption is decreased for these drugs, whereas the rate of elimination is unchanged. bility should be planned for if space medical technology is to remain current.
ClInIcal ImmunologIcal
AdaptatIons to Space
Alterations in the human immune mechanism, and in microorganisms potentially capable of effecting an infectious process, have been studied from the early days of human spaceffight (66-69). Although the derived data have often been incomplete, and sometimes ambiguous, one can draw several general conclusions. Some of the immunological changes reported from the American and Russian studies are summarized in Table 3 . These data indicate that space flight can be expected to produce a blunting of the human cellular immune mechanism concomitant with an increase in potentially pathogenic microorganisms, thereby increasing the probability of mnfiight infectious diseases. During the early days of the American space program, there was a very high incidence of infections before adoption of a preffight health stabilization program. During the Apollo program, crew members experienced upper respiratory problems, influenza, viral gastroenteritis, rhinitis, pharyngitis, and mild dermatological problems (68) . Moreover, long-duration Russian space missions have been curtailed because of outbreaks of infectious disease (78) .
Immunological Response to Spaceflight
The cellular immune response of American and Russian crew members has been studied by various methods for >20 years. However, there remains a paucity of reliable data for conclusions. Considerable immunological testing was performed after the Apollo, Skylab, and ASTP missions (79) . Also, postifight alterations in the in vitro response of cosmonaut lymphocytes were reported after Soyuz and Salyut (80, 81 Table 4 . These comparisons demonstrated that the absolute number of lymphocytes, the ability of these cells to respond to mitogenic stimulation, and the number of eosinophils in the peripheral circulation were typically decreased after ffight. Conversely, there was an almost universal doubling of the absolute neutrophil number, and often a major change in the CD4/CD8 ratio. This latter event resulted from an increase in the helper lymphocyte population, as determined by flow-cytometric analysis (71) . Both the mean number of reactions and the aggregate reaction size within this population were reduced inflight (Figure 3) . Further, the data suggest that on day 4 of a Shuttle mission the CMI system was measurably de- (83) , a connection between these events should be considered.
The presence of functioning delayed hypersensitivity cells is also required for a normal DTH response. These cells are the T lymphocytes that have become sensitized (69, 71 and allows any infectious agents contracted to demonstrate themselves before flight, probably contributed to the significant reduction in microbial problems during and after space missions subsequent to Apollo 13 (75, 78 (68) , and increased resistance of some microorganisms to antibiotics (77) .
A major concern during the pre-Shuttle days was that upon return to Earth, crew members might respond negatively to renewed contact with microorganisms that were largely absent in the spacecraft.
It was thought that reduced exposure to microorganisms inffight would cause a decrease in both host immunocompetence and the presence of competing microflora, which could result in a "microbial shock" upon return and exposure to a normal microbial load. However, samples obtained immediately after landing showed no decrease in potentially pathogenic species. Therefore, the decreased exposure to pathogens is not a factor in predicting inflight or postffight disease probabilities (76, 88, 89) .
Although inflight sampling has been limited, microbiological specimens have been collected routinely before and after Shuttle flights from the Shuttle air and internal surfaces, the crew's food, and the drinking water (90) . Postifight orbiter air samples typically contain fungi (e.g., Aspergillus sp. and Penicillum sp.) and bacteria (e.g., Bacillus sp. and Micrococcus sp.). Additionally, Staphylococcus sp., normally associated with skin, have been recovered in large numbers from the orbiter's internal surfaces, but not from air samples (90) .
Inflight sampling was conducted during the Spacelab 3 mission because of concern about possible contamination from the Research Animal Holding Facility (90, 91 This category may include certain types of immune cell analyses and quantifications, as well as identification of microorganisms other than expected frank pathogens.
Both assay capability and sample storage (especially if refrigerated or frozen) are difficult to provide inflight. Therefore, the decision of whether to do these tests inflight or upon return will be determined by the available facilities.
Technology and DIrectIon for Space ExploratIon
The evolution of clinical laboratory technology has been toward operator-independent, automated, highthroughput systems able to support laboratory requirements of entire hospitals, medical centers, or geographical regions. Automation of sample processing may extend this trend and offer technology capable of being used directly for space medicine applications.
An example is the Integrated Blood-Collection System being developed by Kodak. This system makes use of a sophisticated container for sample collection, sample processing, metering of a discrete volume for analysis, and containment and disposal of excess sample volume (92) . These functions are likely to be important for laboratory analyses in space that require a combination of reagents and sample fluid volume. Both critical care on Earth and medical care in space require efficient use of time and sample volume and may benefit from this technology.
Technology for sophisticated, relatively low-throughput analyzers designed specifically for bedside or ICU applications is likely to be most directly applicable to clinical space medicine.
Developments of the 1980s included physician's office chemistry analyzers and low- 
